European Urology Focus

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

European Urology Focus

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 3, Pages (September 2006)

Volume 70, Issue 3, Pages (September 2016)

Volume 72, Issue 2, Pages (August 2017)

Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database Alexandros Tsikkinis, Nikola.

European Urology Focus

Volume 53, Issue 4, Pages (April 2008)

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

Volume 54, Issue 4, Pages (October 2008)

Volume 70, Issue 4, Pages (October 2016)

Volume 69, Issue 1, Pages (January 2016)

Volume 73, Issue 3, Pages (March 2018)

Volume 70, Issue 4, Pages (October 2016)

Prostate Cancer Epidemic in Sight?

Volume 62, Issue 6, Pages (December 2012)

Volume 61, Issue 1, Pages (January 2012)

Volume 68, Issue 5, Pages (November 2015)

Volume 67, Issue 2, Pages (February 2015)

Volume 68, Issue 5, Pages (November 2015)

Volume 60, Issue 5, Pages (November 2011)

Volume 74, Issue 2, Pages (August 2018)

Marcel J. Steggerda, Henk G. van der Poel, Luc M.F. Moonen

Volume 64, Issue 5, Pages (November 2013)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 70, Issue 5, Pages (November 2016)

Volume 71, Issue 6, Pages (June 2017)

European Urology Oncology

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 2, Pages (February 2014)

Volume 61, Issue 5, Pages (May 2012)

Volume 72, Issue 1, Pages (July 2017)

Validation of Preoperative Nomograms Predicting Lymph Node Involvement in Prostate Cancer: A Bi-institutional Study Alexander I. Hinev, Vesselin I. Hadjiev,

Volume 53, Issue 4, Pages (April 2008)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Volume 58, Issue 1, Pages 1-7 (July 2010)

Volume 71, Issue 1, Pages (January 2017)

Volume 68, Issue 4, Pages (October 2015)

Volume 72, Issue 6, Pages (December 2017)

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective,

European Urology Oncology

Prostate Cancer Nomograms: An Update

The Importance of Testosterone Control in Prostate Cancer

Testicular Cancer Variations in Time and Space in Europe

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical.

European Urology Oncology

Volume 49, Issue 6, Pages (June 2006)

European Urology Oncology

Long-Term Hormonal Therapy: Who Would Benefit?

European Urology Oncology

European Urology Oncology

Volume 59, Issue 4, Pages (April 2011)

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

Volume 75, Issue 3, Pages (March 2019)

European Urology Oncology

Volume 50, Issue 5, Pages (November 2006)

European Urology Oncology

Volume 68, Issue 5, Pages (November 2015)

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Volume 68, Issue 5, Pages (November 2015)

Volume 52, Issue 6, Pages (December 2007)

Treatment Options in Prostate Cancer Once Primary Therapy Fails

European Urology Oncology

Presentation transcript:

European Urology Focus The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer- related Death Using Competing-risk Analysis Lorenzo Tosco, Annouschka Laenen, Alberto Briganti, Paolo Gontero, R. Jeffrey Karnes, Patrick J. Bastian, Piotr Chlosta, Frank Claessens, Felix K. Chun, Wouter Everaerts, Christian Gratzke, Maarten Albersen, Markus Graefen, Burkhard Kneitz, Giansilvio Marchioro, Rafael Sanchez Salas, Bertrand Tombal, Thomas Van den Broeck, Henk Van Der Poel, Jochen Walz, Gert De Meerleer, Alberto Bossi, Karin Haustermans, Hendrik Van Poppel, Martin Spahn, Steven Joniau European Urology Focus DOI: 10.1016/j.euf.2016.12.008 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Cumulative incidence curves by prognostic group for predicting prostate cancer–related death based on postoperative pathological features (95% confidence intervals are represented by dotted lines). European Urology Focus DOI: (10.1016/j.euf.2016.12.008) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Comparison of cumulative mortality curves showing deaths due to prostate cancer or other causes in the prognostic groups indicated. PCRD=prostate cancer–related death; OCM=other-cause mortality; CI=confidence interval. European Urology Focus DOI: (10.1016/j.euf.2016.12.008) Copyright © 2017 European Association of Urology Terms and Conditions